Praemium (PPS) COMPANY REPORT. Model performance

Similar documents
Praemium (PPS) COMPANY REPORT. Quartermaster

APN Outdoor Group (APO)

Insurance Brokers SECTOR REPORT. Solid Hold. -4% Jun-12. Dec-12. Mar-13. Sep-13. Sep-12. Jun-13. Source: APRA, Baillieu Holst estimates

Vita Group (VTG) COMPANY REPORT. Vitality in question

Genex Power (GNX) COMPANY REPORT. NAIF lined up for Stage 2

Freedom Insurance (FIG)

Pacific Energy (PEA)

SeaLink Travel Group (SLK)

Appen (APX) COMPANY REPORT

Bass Metals (BSM) COMPANY REPORT INITIATION OF COVERAGE. Starting small in graphite

Gold Road Resources (GOR)

Australian Strategy Insight

Kibaran Resources (KNL)

Pacific Energy (PEA)

Australian Equity Research

BUY SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS

Asset Allocator INVESTMENT STRATEGY. Extreme Underweight

Zip Co. Delivering against expectations. Last Price A$0.86 Target Price A$0.90 (Previously A$0.88) Recommendation Accumulate Risk Higher.

Hybrids Daily. Commentary on yesterday s market FIG.1: UP FIG.2: DOWN FIG.3: BEST SWITCH FIG.4: UPCOMING DISTRIBUTIONS FIG.5: THE SWAP CURVE 2.

Hybrids Daily. Commentary on yesterday s market FIG.1: UP FIG.2: DOWN FIG.3: BEST SWITCH FIG.4: UPCOMING DISTRIBUTIONS FIG.5: THE SWAP CURVE 3.

Company Review 1300SMILES. Corporate Activity Dental Partners. ONT A$6.72 (TP $6.26) Recommendation Hold (no change) Risk Assessment Medium

Wisr Ltd (DirectMoney)

Company Review. Centaurus Metals. Jambreiro Resource upgrade. CTM A$0.08 Recommendation Buy Risk Assessment High

Zip Co. Improved medium term cost guidance. Last Price A$0.96 Target Price A$1.00 (Previously A$0.90) Recommendation Accumulate Risk Higher

Consolidated Operations Group (COG)

Wisr Ltd (DirectMoney)

Wisr Ltd. New products to underpin growth

Resetting expectations

MNF Group Limited (MNF)

Asset revaluation driven by almonds

Noni B (NBL) SFH acquisition could be up to 60% EPS accretive. Key points. Risks and catalysts

MacPhersons Resources (MRP)

Managed Accounts Holdings

MotorCycle Holdings (MTO) New HOLD: Harley still lacking traction. Key points. Risks and catalysts

OneVue Holdings (OVH)

Cash Converters Intl.

SPS Managed Portfolios Aust Equities Income Portfolio

Boart Longyear. Earnings and target price revision. No change. Price catalyst. Action and recommendation

Noni B (NBL) BUY: FY18e EBITDA +12.8% Key points. Risks and catalysts

Cardno. Tough half over A$2.88 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Listed Investment Companies (LICs)

Perpetual (PPT) Oversold, upgrade to Buy. Over 6% yield, with upside in market rally. Quarterly highlights. Earnings revisions

OneVue Holdings (OVH)

Port of Tauranga. Investor Day update. Investor Day focuses on competitive advantages. Forecast revisions; EPS changes are immaterial (Fig 4)

SG Fleet Group. Another UK acquisition. Earnings and target price revision

Sims Metal Management

Platinum Asset Management

Big River Industries Limited (ASX:BRI)

IOOF. Positive flows in 1Q17. FUM and Net Flows for September Qtr Source: Company data, Macquarie Research, Oct 2016.

Pinnacle Investment Management

COMPUMEDICS LTD HOLD. CMP Downgrades FY17 Guidance COMPANY UPDATE EVENT KEY TAKE-AWAYS INVESTMENT VIEW

Recycling assets at a premium. Vector to sell non-auckland gas assets at a premium. We view the transaction as value accretive

Eddie Stobart Logistics

APN Property Group (APD) Buy Share Price: A$0.41

WINDLAB LTD HOLD. Lakeland financial close delayed again. Downgrade to HOLD. COMPANY UPDATE EVENT IMPACT INVESTMENT VIEW

Westoz Investment Company. October 2018

Aveo presentation at Morgans Queensland Conference 2016

Platinum Asset Management (PTM)

Aventus Retail Property Fund

CENTREPOINT ALLIANCE LIMITED (CAF)

Codan Ltd (CDA) EQUITY RESEARCH Information Technology. Solid first half momentum, positioned for even better second.

AtCor Medical Holdings Limited (ACG)

Sample. Virtus Health Ltd. Financial Analysis VRT $7.15. No Holding at Time of Report

Managed Accounts Holdings

Zespri. Vote for change and SunGold licence sales underpin a strong outlook COMPANY RESEARCH. Private Wealth Research

Cooks Global Foods Ltd

MEDICAL DEVELOPMENTS INTERNATIONAL LTD

Adacel Technologies (ADA)

Goodbaby (1086 HK) Buy (maintained) Target price: HK$ H16 results miss, but margin expansion continues. Equity Research Consumer Discretionary

Nanosonics Limited. Australia Health Care Equipment & Supplies. Growth outlook unchanged. Earnings Forecasts. Source Company, LINWAR Research

China Renewable Energy Investment Ltd (987_HK)

For personal use only

UBS Investment Research Brambles Limited

Downer EDI Two out of three ain t bad Event

Regional Express Holdings Ltd REX

Generation Healthcare REIT

FY17 RESULTS. Tuesday 20 February 2018

Rajesh Exports (RJEX_IN) Earnings Update Report Consumer Discretionary: Gold Jewelry Manufacturer

Tatts Group. Earnings and target price revision. Price catalyst. Action and recommendation. Maintain Underperform on valuation grounds.

Tabcorp Holdings Limited. 2014/15 Full Year Results Presentation 13 August 2015

UGL. Driving growth in DTZ. Earnings and target price revision. No change. Price catalyst. Action and recommendation

For personal use only. FY2017 H1 Results February 2017

Company Review. Horizon Oil Limited (HZN) FY14 results full year China impact. Last price $0.34

Results Review. 3QFY13: Downsizing its workforce. Technology Bloomberg Ticker: UNI MK Bursa Code: November 2013

QBE Insurance. QBE ANZ performance: LMI vs. Excl. LMI (A$m) Source: Company data, Macquarie Research, April 16. Earnings and target price revision

SG Fleet Group % growth in FY17. Earnings and target price revision. Price catalyst. Catalyst: Results and contract wins.

Fund Managers. Aust. Fund managers review & rank AUSTRALIA. Event. Stock Views

INDEPTH RESEARCH NOTE Brambles Ltd Buy

Earnings and target price revision. Price catalyst. Action and recommendation

SomnoMed (SOM) An eye on RSS channel conflict but the core offering to prevail in US direct market. Key points. Risks and catalysts

KPIT CUMMINS INFOSYSTEMS Ltd.

Auckland International Airport

PRICE $1.16 Regional Express Holdings Ltd REX

Aged Care. Propco sale & lease back A$2.71 A$5.75 A$6.15 AUSTRALIA. Event. Impact. Outlook

Crown Resorts. A favourable risk/reward setting A$12.94 AUSTRALIA. Event. Impact. Earnings and target price revision.

Family Zone Cyber Safety Limited (FZO) Company Update. Investment Summary. Investment Highlights. Investment Recommendation

Kangaroo Island Plantation Timbers (KPT) BUY Share Price: A$2.15. NTA uplift buffers project delays Target Price: A$2.71

Vista Group International

For personal use only 1H17 RESULTS PRESENTATION

Invocare. Well-positioned. Earnings and target price revision. Price catalyst. Catalyst: FY12 results. Action and recommendation

Transcription:

14 August 2017 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk High Price Target $0.58 Share Price $0.41 SNAPSHOT Monthly Turnover $9.5mn Market Cap $165mn Shares Issued 398.5mn 52-Week High $0.54 52-Week Low $0.32 Sector Information Technology BUSINESS DESCRIPTION Praemium is a technology provider to the global wealth management sector. It provides technology platforms for investment and portfolio administration, separately managed accounts (SMAs) and financial planning. PPS administers over 300,000 client accounts, has over $80bn in assets under administration and has relationships with over 900 institutions. PPS has operations in Australia, Europe and Asia. 12-MONTH PRICE & VOLUME RESEARCH ANALYST Nicolas Burgess, CFA + 613 9602 9379 nburgess@baillieuholst.com.au Piers Flanagan +613 9282 8127 pflanagan@baillieuholst.com.au Josh Kannourakis + 613 9602 9265 jkannourakis@baillieuholst.com.au Disclosure The author owns no shares in PPS. Praemium (PPS) COMPANY REPORT Model performance Overall: PPS s underlying earnings result was a touch ahead of our expectations, with excellent revenue trends and margin expansion. BUY. FY17 result: PPS reported underlying EBITDA of $6.3m, up 54% over the year and just ahead of our equivalent forecast of $6.0m. Pre-tax profit of $2.2m was just below our $2.6m forecast due to one-off expenses (total normalised costs of $3.2m were higher than our $2.5m forecast due to restructuring). Profit after tax of $0.7m was also less-than-expected with a tax expense of $1.5m, much higher than our $1.0m forecast. Drivers/surprises: FY17 gross revenue of $35.4m was up 17% and in line with our forecast of $35.8m. By product type, SMA revenue was up 44% to $17.2m on the back of 28% growth in funds under administration (FUA) and improving sales from PPS s in-house investment management products. Portfolio Services recorded 8% revenue growth to $14.7m, driven by new client wins. Underlying expenses of $29.1m were up 11% over the year and less than our forecast $30.3m, driving 54% growth in EBITDA to $6.3m. The Australian business reported EBITDA of $10.6m at a margin of 46%, whilst the UK saw its EBITDA loss improve 33% over the year to -$2.2m. Overall, the company improved its EBITDA margin from 14% in FY16 to 18% in FY17. Key takeaways: Since 1 Jul-17, PPS has grown its Australian SMA FUA by 7.2% to $4.15bn and the International SMA FUA by 5.4% to $ 1.37bn, reflecting a very strong start to the year. Meanwhile, the company remains well capitalised with no debt and $9.0m cash in the bank. Changes to EPS: We increase our FY18F underlying EPS forecasts by 2.6% and reduce our FY19F forecasts by 9.4%. Our valuation and price target increase from $0.55 to $0.58 given the roll-forward. Investment view: PPS continues to show good momentum across new business flows, funds under administration, revenue and profit. We reiterate a BUY rating. Key attributes of our investment thesis include a growing managed accounts market as retail investor s switch from other fund structures, growth initiatives from higher margin products in international markets, new capabilities and scale following strategic acquisitions and potential corporate appeal (wealth technology likely to be part of the next wave of financial service consolidation, in our view). The company s valuation is not demanding trading on an FY18F PE of 31x with a two-year EPS CAGR of 37% EPS growth. INVESTMENT SUMMARY Year End: 30 June 2016 (A) 2017 (A) 2018 (E) 2019 (E) 2020 (E) Revenue $mn 29 33 39 46 51 EBITDA $mn 4.2 6.3 9.3 13.2 15.4 EBIT $mn 3.3 5.4 8.2 12.0 14.2 Reported Profit $mn 0.8 0.6 4.6 6.9 8.6 Adjusted Profit $mn 2.2 3.9 5.3 7.5 8.9 EPS (Reported) 0.2 0.2 1.1 1.7 2.1 EPS (Adjusted) 0.6 1.0 1.3 1.9 2.2 EPS Growth % N/A 75.7 33.8 40.1 18.2 PER (Reported) x 198.8 258.4 35.8 23.9 19.4 PER (Adjusted) x 72.7 41.4 30.9 22.1 18.7 Dividend 0.0 0.0 0.0 1.0 1.1 Yield % 0.0 0.0 0.0 2.3 2.7 Franking % 0 0 0 0 100 Baillieu Holst Ltd ABN 74 006 519 393 www.baillieuholst.com.au Please read the disclaimer at the end of this report. Page 1

Financial summary Code: PPS Rating: BUY Analyst: Nicolas Burgess Price Target: $0.58 Date: 14 August, 2017 Upside/downside: 41.8% Share Price: $0.41 Valuation: $0.48 Market Capitalisation: $163m Valuation method: DCF / EV/EBITA Year End: 30 June Risk: High PROFIT & LOSS (A$m) FY16A FY17A FY18E FY19E FY20E EARNINGS FY16A FY17A FY18E FY19E FY20E Net revenue 29.30 32.80 38.74 46.01 50.88 EPS - Underling cash (diluted) 0.6 1.0 1.3 1.9 2.2 Operations -6.20-6.80-7.75-9.20-10.18 EPS Growth - underlying 214% 76% 34% 40% 18% Gross Margin 23.10 26.00 30.99 36.81 40.70 EPS - Reported (diluted) 0.2 0.2 1.1 1.7 2.1 Costs -18.90-19.70-21.67-23.62-25.27 Diluted shares (m) 395.3 397.8 400.6 403.8 405.5 EBITDA 4.20 6.30 9.32 13.19 15.43 DPS (cps) 0.0 0.0 0.0 1.0 1.1 Depreciation & amortisation -0.86-0.94-1.16-1.21-1.27 Payout Ratio 0% 0% 0% 51% 50% EBIT 3.35 5.36 8.16 11.98 14.16 Franking 0% 0% 0% 0% 100% Other -1.73-3.20-1.10-1.30-1.00 Net interest 0.00 0.00 0.00 0.00 0.00 VALUATION FY16A FY17A FY18E FY19E FY20E PBT 1.62 2.16 7.06 10.68 13.16 Underlying P/E (x) 72.7 41.4 30.9 22.1 18.7 Tax -0.80-1.53-2.47-3.74-4.60 EV/EBITDA (x) 35.2 23.7 15.2 10.2 8.2 Minorities 0.00 0.00 0.00 0.00 0.00 EV/EBIT (x) 44.1 27.8 17.4 11.2 9.0 Reported NPAT 0.82 0.63 4.59 6.94 8.55 Dividend Yield (%) 0.0% 0.0% 0.0% 2.3% 2.7% Price/Book (x) 10.0 9.5 7.3 6.4 5.4 Add back: Price/NTA (x) 13.6 12.8 9.1 7.6 6.4 Non-recurring items (net tax) 1.41 3.31 0.72 0.56 0.35 Price/FCF 314.1 244.9 23.5 16.9 14.5 Underlying cash profit 2.23 3.94 5.31 7.50 8.90 GROWTH FY16A FY17A FY18E FY19E FY20E Revenue growth 20.1% 11.9% 18.1% 18.8% 10.6% BALANCE SHEET (A$m) FY16A FY17A FY18E FY19E FY20E Operating cost growth 1.6% 9.7% 13.9% 18.8% 10.6% Assets EBITDA growth 90.9% 50.0% 48.0% 41.4% 17.0% Cash 10.43 8.98 15.98 23.84 31.14 PBT growth 8.1% 33.8% 226.9% 51.2% 23.2% Receivables 5.34 6.69 5.04 5.98 6.61 Underlying NPAT growth -138.5% -22.6% 627.6% 51.2% 23.2% PPE 0.90 1.24 1.24 1.24 1.24 Reported NPAT growth -216.6% 76.8% 34.7% 41.2% 18.7% Intangibles 4.31 4.38 4.38 4.38 4.38 MARGINS & RETURNS FY16A FY17A FY18E FY19E FY20E Tax assets 0.62 0.63 0.63 0.63 0.63 EBITDA Margin 14.3% 19.2% 24.1% 28.7% 30.3% Other assets 1.79 2.24 2.24 2.24 2.24 EBIT Margin 11.4% 16.3% 21.1% 26.0% 27.8% Total Assets 23.38 24.17 29.51 38.31 46.24 NPBT Margin 5.5% 6.6% 18.2% 23.2% 25.9% Liabilities ROIC 42.0% 26.4% 83.4% 197.9% 1237% Payables 3.81 5.36 5.04 5.98 6.61 ROE 13.9% 23.7% 26.9% 30.9% 31.5% Debt 0.00 0.00 0.00 0.00 0.00 ROA 18.3% 26.5% 34.7% 38.9% 36.5% Provisions 1.04 1.13 1.13 1.13 1.13 Effective Tax Rate 49.5% 70.8% 35.0% 35.0% 35.0% Other liabilities 2.3 0.6 0.9 5.1 8.0 Total Liabilities 7.1 7.1 7.1 12.2 15.7 GEARING FY16A FY17A FY18E FY19E FY20E Equity Net Debt / (cash) (A$m) -10.4-9.0-16.0-23.8-31.1 Share capital 64.1 64.8 64.8 64.8 64.8 Enterprise value 147.6 149.1 142.1 134.2 126.9 Retained earnings -48.4-47.7-42.4-38.7-34.3 Net Debt/Equity (%) -64% -53% -71% -91% -102% Other equity 0.54-0.04-0.04-0.04-0.04 EBITDA/Net interest na na na na na Total shareholders equity 16.24 17.09 22.40 26.07 30.52 OPERATIONAL DATA FY16A FY17A FY18E FY19E FY20E Revenue by Product (A$m): BV per share (cps) 4.11 4.30 5.59 6.46 7.53 Portfolio Services 13.60 14.70 15.86 16.16 12.43 NTA per share (cps) 3.02 3.20 4.50 5.37 6.45 SMA - Australia 6.50 8.40 10.89 13.66 16.75 SMA - Intenational 5.20 7.50 10.19 14.55 20.24 Financial Planning 1.90 2.10 2.30 2.41 2.53 CASH FLOW (A$M) FY16A FY17A FY18E FY19E FY20E Corporate / other 2.90 2.70 2.36 2.36 2.38 Cash at Start 11.1 10.0 8.6 15.6 23.4 Group revenue 30.10 35.40 41.60 49.15 54.34 Cash from from ops 1.0 1.5 7.8 10.7 12.5 Growth 23.4% 17.6% 17.5% 18.2% 10.5% Capex -0.5-0.9-0.8-0.9-1.0 Free cash flow 0.5 0.7 7.0 9.8 11.4 Funds on Platform (A$bn): Free cash flow per share (cps) 0.1 0.2 1.7 2.4 2.8 Australia 3.01 3.87 5.05 6.33 7.63 Cash flow from investing -1.0-2.1-0.8-0.9-1.0 International 1.76 2.20 3.16 4.30 5.82 Cash flow from financing 0.0 0.0 0.0-1.9-4.1 Group 4.77 6.07 8.22 10.63 13.45 Cash at end 10.0 8.6 15.6 23.4 30.7 Growth 25.2% 27.3% 35.3% 29.4% 26.5% GOCF / EBITDA 20% 76% 95% 95% 95% FCF / Underlying cash NPAT 23% 17% 132% 130% 129% Baillieu Holst Ltd ABN 74 006 519 393 www.baillieuholst.com.au Please read the disclaimer at the end of this report. Page 2

Model performance Overall: PPS s underlying earnings result was a touch ahead of our expectations, with excellent revenue trends and margin expansion. BUY. FY17 result: PPS reported underlying EBITDA of $6.3m, up 54% over the year and just ahead of our equivalent forecast of $6.0m. Pre-tax profit of $2.2m was just below our $2.6m forecast due to one-off expenses (total normalised costs of $3.2m were higher than our $2.5m forecast due to restructuring). Profit after tax of $0.7m was also less-than-expected with a tax expense of $1.5m, much higher than our $1.0m forecast. FIG.1: PPS FY17 RESULT SUMMARY FY17 gross revenue of $35.4m was up 17% and in line with our forecast of $35.8m. By product type, SMA revenue was up 44% to $17.2m on the back of 28% growth in funds under administration (FUA) and improving sales from PPS s in-house investment management products. Portfolio Services recorded 8% revenue growth to $14.7m, driven by new client wins. Underlying expenses of $29.1m are up 11% over the year and less than our forecast $30.3m, driving 54% growth in underlying EBITDA to $6.3m. The Australian business reported EBITDA of $10.6m at a margin of 46%, whilst the UK saw its EBITDA loss improve 33% over the year to -$2.2m. Overall, the company improved its EBITDA margin from 14% in FY16 to 18% in FY17. Baillieu Holst Ltd ABN 74 006 519 393 www.baillieuholst.com.au Please read the disclaimer at the end of this report. Page 3

FIG.2: PPS FY17 RESULT BY GEOGRAPHY Key takeaways: Since 1 Jul-17, PPS has grown its Australian SMA FUA by 7.2% to $4.15bn and the International SMA FUA by 5.4% to $ 1.37bn, reflecting a very strong start to the year. Meanwhile, the company remains well capitalised with no debt and $9.0m cash in the bank. FIG.3: PPS FY17 RESULT AUSTRALIA HIGHLIGHTS Changes to EPS: We increase our FY18F underlying EPS forecasts by 2.6% and reduce our FY19F forecasts by 9.4%. Baillieu Holst Ltd ABN 74 006 519 393 www.baillieuholst.com.au Please read the disclaimer at the end of this report. Page 4

FIG.4: PPS FY17 RESULT INTERNATIONAL HIGHLIGHTS Investment view We reiterate a BUY rating. Our valuation and price target increase from $0.55 to $0.58 due to the year-end rollforward. PPS continues to show good momentum across new business flows, funds under administration, revenue and profit. Key attributes of our investment thesis include a growing managed accounts market as retail investor s switch from other fund structures, growth initiatives from higher margin products in international markets, new capabilities and scale following strategic acquisitions and potential corporate appeal (wealth technology likely to be part of the next wave of financial service consolidation, in our view). The company s valuation is not demanding trading on an FY18F PE of 31x with a two-year EPS CAGR of 37% EPS growth. FIG.5: PPS STRATEGIC PRIORITIES Baillieu Holst Ltd ABN 74 006 519 393 www.baillieuholst.com.au Please read the disclaimer at the end of this report. Page 5

Appendix FIG.6: LONG TERM MOMENTUM INDICATORS Source: Iress FIG.7: SHORT TERM MOMENTUM INDICATORS Source: Iress Baillieu Holst Ltd ABN 74 006 519 393 www.baillieuholst.com.au Please read the disclaimer at the end of this report. Page 6

This document has been prepared and issued by: Baillieu Holst Ltd ABN 74 006 519 393 Australian Financial Service Licence No. 245421 Participant of ASX Group Participant of NSX Ltd Analysts stock ratings are defined as follows: Buy: The stock s total return is expected to increase by at least 10-15 percent from the current share price over the next 12 months. Hold: The stock s total return is expected to trade within a range of ±10-15 percent from the current share price over the next 12 months. Sell: The stock s total return is expected to decrease by at least 10-15 percent from the current share price over the next 12 months. Baillieu Holst Analysts stock ratings distribution as of 30 May 2017: Buy: 64% Hold: 33% Sell: 3% Disclosure of potential interest and disclaimer: Baillieu Holst Ltd (Baillieu Holst) and/or its associates may receive commissions, calculated at normal client rates, from transactions involving securities of the companies mentioned herein and may hold interests in securities of the companies mentioned herein from time to time. Your adviser will earn a commission of up to 55% of any brokerage resulting from any transactions you may undertake as a result of this advice. When we provide advice to you, it is based on the information you have provided to us about your personal circumstances, financial objectives and needs. If you wish to rely on our advice, it is important that you inform us of any changes to your personal investment needs, objectives and financial circumstances. If you do not provide us with the relevant information (including updated information) regarding your investment needs, objectives and financial circumstances, our advice may be based on inaccurate information, and you will need to consider whether the advice is suitable to you given your personal investment needs, objectives and financial circumstances. Please do not hesitate to contact our offices if you need to update your information held with us. Please be assured that we keep your information strictly confidential. No representation, warranty or undertaking is given or made in relation to the accuracy of information contained in this advice, such advice being based solely on public information which has not been verified by Baillieu Holst Ltd. Save for any statutory liability that cannot be excluded, Baillieu Holst Ltd and its employees and agents shall not be liable (whether in negligence or otherwise) for any error or inaccuracy in, or omission from, this advice or any resulting loss suffered by the recipient or any other person. Past performance should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied, is made regarding future performance. Information, opinions and estimates contained in this report reflect a judgment at its original date of publication and are subject to change without notice. The price, value of and income from any of the securities or financial instruments mentioned in this report can fall as well as rise. The value of securities and financial instruments is subject to exchange rate fluctuation that may have a positive or adverse effect on the price or income of such securities or financial instruments. Baillieu Holst Ltd assumes no obligation to update this advice or correct any inaccuracy which may become apparent after it is given. Baillieu Holst Ltd ABN 74 006 519 393 Australian Financial Service Licence No. 245421 Participant of ASX Group Participant of NSX Ltd www.baillieuholst.com.au Melbourne (Head Office) Address Level 26, 360 Collins Street Melbourne, VIC 3000 Australia Postal PO Box 48, Collins Street West Melbourne, VIC 8007 Australia Phone +61 3 9602 9222 Facsimile +61 3 9602 2350 Email melbourne@baillieuholst.com.au Adelaide Office Address Ground Floor, 226 Greenhill Road, Eastwood SA 5063 Postal PO Box 171 Fullarton SA 5063 Phone +61 8 7074 8400 Facsimile +61 8 8362 3942 Email adelaide@baillieuholst.com.au Bendigo Office Address Level 1, 10-16 Forest Street Bendigo, VIC 3550 Postal PO Box 84 Bendigo, VIC 3552 Phone +61 3 4433 3400 Facsimile +61 3 4433 3430 Email bendigo@baillieuholst.com.au Geelong Office Address 16 Aberdeen Street Geelong West Vic 3218 Postal PO Box 364 Geelong Vic 3220 Australia Phone +61 3 5229 4637 Facsimile +61 3 4229 4142 Email geelong@baillieuholst.com.au Gold Coast Office Address Suite 202 Level 2, Eastside Building 6 Waterfront Place, Robina QLD 4226 Phone +61 7 5628 2670 Facsimile +61 7 5677 0258 Email goldcoast@baillieuholst.com.au Newcastle Office Address Level 1, 120 Darby Street Cooks Hill, NSW 2300 Australia Postal PO Box 111 The Junction, NSW 2291 Australia Phone +61 2 4037 3500 Facsimile +61 2 4037 3511 Email newcastle@baillieuholst.com.au Perth Office Address Level 10, 191 St Georges Terrace Perth WA 6000 Australia Postal PO Box 7662, Cloisters Square Perth, WA 6850 Australia Phone +61 8 6141 9450 Facsimile +61 8 6141 9499 Email perth@baillieuholst.com.au Sydney Office Address Level 40, 259 George Street Sydney, NSW 2000 Australia Postal PO Box R1797 Royal Exchange, NSW 1225 Australia Phone +61 2 9250 8900 Facsimile +61 2 9247 4092 Email sydney@baillieuholst.com.au Baillieu Holst Ltd ABN 74 006 519 393 www.baillieuholst.com.au Page 7